Loading ...

user Admin_Adham
21st Mar, 2024 12:00 AM
Test

Novo Nordisk's Once-weekly Basal Insulin Icodec Recommended for Marketing Approval in Europe

COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk on Thursday said its once-weekly basal insulin icodec for treatment of diabetes in adults had received a recommendation for marketing authorisation from the European Medicines Agency's human medicines committee.

(Reporting by Stine Jacobsen, eiditn by Anna Ringstrom)

TOP PICKS FOR YOU


Share This Article

Comments

Leave a comment